Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

NDA filed in U.S. for once-daily Xatral

Jan. 25, 2001

Binding and functional activity of the first truly selective alpha1A antagonist characterized

Jan. 24, 2001

Potential new therapy for erectile dysfunction presented by Dong-A

Jan. 22, 2001

YM-905 enters late-stage clinical development overseas

Jan. 19, 2001

Acute and chronic antidiuretic effects of OPC-51803, a nonpeptide V2 receptor agonist

Jan. 11, 2001

Rho kinase antagonism as a therapeutic alternative for erectile dysfunction

Jan. 4, 2001

Once-daily Detrol approved by FDA for treatment of overactive bladder

Dec. 27, 2000

Taisho presents new compounds with potential in the treatment of renal and cardiovascular conditions

Dec. 22, 2000

Vivus granted third PDE inhibitor patent

Dec. 21, 2000

Cialis shows promise as ED therapy in phase II

Dec. 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...